Literature DB >> 24427363

Transformation of follicular lymphoma in the retroperitoneal muscles demonstrated by CT-guided needle biopsy of FDG-avid lesions; case series.

Masahiro Uni1, Fumihiko Nakamura1, Akihide Yoshimi2, Aya Shinozaki-Ushiku3, Atsuko Hosoi3, Kumi Nakazaki1, Yasuhito Nannya1, Masashi Fukayama3, Mineo Kurokawa2.   

Abstract

We herein report two cases of relapsed follicular lymphoma (FL) with transformation in the retroperitoneal muscles. Fluorodeoxyglucose (FDG)-positron emission tomography (PET) combined with computed tomography (CT) showed high uptakes in the retroperitoneal muscles. We considered excisional biopsy at first, since it is definitely the most reliable means to obtain histological diagnosis. However, excisional biopsy of the retroperitoneal muscles is challenging for anatomical reasons. Moreover, our patients were kept under poor performance status. Thus, CT-guided percutaneous needle biopsy of FDG-avid retroperitoneal muscles was performed. Histopathological examination of the biopsied specimens demonstrated proliferation of transformed large B cells in both cases. Sheets of large B cells were also recorded in one case. CT-guided needle biopsy is less prioritized than excisional biopsy because of limited information on tissue architecture and increasingly complicated WHO classification. Our series indicate that image-guided needle biopsy of FDG-avid lesions is sufficient for the diagnosis of transformation. Higher priority should be given to this method in the setting of transformed aggressive lymphoma.

Entities:  

Keywords:  CT-guided needle biopsy; FDG-avid; Follicular lymphoma; retroperitoneum; transformation

Mesh:

Substances:

Year:  2013        PMID: 24427363      PMCID: PMC3885497     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

Authors:  Y Bastion; C Sebban; F Berger; P Felman; G Salles; C Dumontet; P A Bryon; B Coiffier
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

2.  CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies.

Authors:  R Agid; M Sklair-Levy; A I Bloom; S Lieberman; A Polliack; D Ben-Yehuda; Y Sherman; E Libson
Journal:  Clin Radiol       Date:  2003-02       Impact factor: 2.350

3.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Authors:  Heiko Schöder; Ariela Noy; Mithat Gönen; Lijun Weng; David Green; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

4.  Combined core needle biopsy and fine-needle aspiration with ancillary studies correlate highly with traditional techniques in the diagnosis of nodal-based lymphoma.

Authors:  Catalina Amador-Ortiz; Ling Chen; Anjum Hassan; John L Frater; Richard Burack; TuDung T Nguyen; Friederike Kreisel
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

5.  Efficacy of CT-guided percutaneous needle biopsy in the diagnosis of malignant lymphoma at first presentation.

Authors:  Luca Balestreri; Sandro Morassut; Daniele Bernardi; Marcello Tavio; Renato Talamini; Annunziata Gloghini; Antonino Carbone
Journal:  Clin Imaging       Date:  2005 Mar-Apr       Impact factor: 1.605

6.  Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Authors:  Silvia Montoto; Andrew John Davies; Janet Matthews; Maria Calaminici; Andrew J Norton; John Amess; Sarah Vinnicombe; Rachel Waters; Ama Z S Rohatiner; T Andrew Lister
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

7.  The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL).

Authors:  A Noy; H Schöder; M Gönen; M Weissler; K Ertelt; C Cohler; C Portlock; P Hamlin; H W D Yeung
Journal:  Ann Oncol       Date:  2009-01-12       Impact factor: 32.976

8.  Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Authors:  Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

Review 9.  Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

Authors:  Eric Wong; Michael Dickinson
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

10.  An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.

Authors:  A J Garvin; R M Simon; C K Osborne; J Merrill; R C Young; C W Berard
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.